Atlas FDA

Stellarex 035 Drug Coated Balloon Percutaneous Transluminal Angioplasty Catheter

FDA premarket approval P160049/S013 · decided 2021-11-18

Approval details

PMA number
P160049
Supplement
S013
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Labeling Change - PAS
Trade name
Stellarex 035 Drug Coated Balloon Percutaneous Transluminal Angioplasty Catheter
Generic name
Drug-Eluting Peripheral Transluminal Angioplasty Catheter
Applicant
The Spectranetics Corp.
Date received
2021-09-17
Decision date
2021-11-18
Days to decision
62 days
Decision code
APPR
Product code
ONU
Advisory committee
Cardiovascular
Expedited review
No
Location
Fremont, CA
Statement
Approval for updated labeling to include your 5-year PAS results.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.